# FDA WARNING_LETTER - Stason Pharmaceuticals, Inc. - October 25, 2019

Source: https://www.globalkeysolutions.net/records/warning_letter/stason-pharmaceuticals-inc/785e47c0-b5ba-4ef1-8e59-3453b4f044e1

> FDA WARNING_LETTER for Stason Pharmaceuticals, Inc. on October 25, 2019. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Stason Pharmaceuticals, Inc.
- Inspection Date: 2019-10-25
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Officers

- [Mariza Jafary](https://www.globalkeysolutions.net/people/mariza-jafary/307fe792-b470-40dd-b29a-40d8b631bf4e)
- [Program Division Director](https://www.globalkeysolutions.net/people/steven-e-porter/5448db0e-32f0-4e98-8a5f-9f0857373b06)

Company: https://www.globalkeysolutions.net/companies/stason-pharmaceuticals-inc/f8669d38-d60b-4f0c-856a-ac536c422fae

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6